Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice

International Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 951-955

  Schlagbauer Wadl, Hermine ^a   Jansen, Burkhard ^a   Müller, Markus ^a   Polterauer, Peter ^a   Wolff, Klaus ^a   Eichler, Hans Georg ^a   Pehamberger, Hubert ^a   Konak, Edith ^b   Johnson, Judith P ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER TRANSPLANTATION; CELL ADHESION; CELL AGGREGATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; GLYCOPROTEIN SYNTHESIS; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD146; BRAIN NEOPLASMS; CELL DIVISION; FEMALE; HEART NEOPLASMS; HUMANS; INTESTINAL NEOPLASMS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; NEOPLASM METASTASIS; NEURAL CELL ADHESION MOLECULES; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SPLENIC NEOPLASMS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032969463     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990611)81:6<951::AID-IJC18>3.0.CO;2-V     Document Type: Article

References (29)

1. ALBELDA, S.M., Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest., 68, 4-17 (1993).
2. BAFETTI, L.M., YOUNG, T.N., ITOH, Y. and STACK, M.S., Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. biol. Chem., 273, 143-49 (1998).
3. BANI, M.R., RAK, J., ADACHI, D., WILTSHIRE, R., TRENT, J.M., KERBEL, R.S., and BEN-DAVID, Y., Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Cancer Res., 56, 3075-3086 (1996).
4. BARDIN, N., FRANCES, V., LESAULE, G., HORSCHOWSKI, N., GEORGE, F. and SAMPOL, J., Identification of the S-Endo 1 endothelial-associated antigen. Biochem. biophys. Res. Comm., 21, 210-216 (1996).
5. BOSMA, G.C., CUSTER, R.P., and BOSMA, M.J., A severe combined immunodeficiency in the mouse. Nature (Lond.), 301, 527-530 (1983).
6. EDWARD, M., Integrins and other adhesion molecules involved in melanocytic tumor progression. Curr. Opin. Oncol., 7, 185-191 (1995).
7. FILSHIE, R.J.A., ZANNETTINO, A.C.W., MAKRYNIKOLA, V., GRONTHOS, S., HENNIKER, A.J., BENDALL, L.J., GOTTLIEB, D., SIMMONS, P.J. and BRADSTOCK, K.F., MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia, 12, 414-421 (1998).
8. HART, I.R., BIRCH, M. and MARSHALL, J.F., Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev., 10, 115-128 (1991).
9. HOLZMANN, B., BRÖCKER, E.B., LEHMANN, J.M., RUTTER, D.J., SORG, C., RIETHMÜLLER, G. and JOHNSON, J.P., Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int. J. Cancer, 39, 466-471 (1987).
10. JOHNSON, J.P., BAR-ELI, M., JANSEN, B. and MARKHOF, E., Melanoma progression-associated glycoprotein MUC18 / MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand. Int. J. Cancer, 76, 769-774 (1997).
11. JOHNSON, J.P., RUMME, M.M., ROTHBÄCHER, U. and SERS, C., MUC18: A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. Curr. Top. Microbiol. Immuuol., 213, 95-105, (1996).
12. KEIJZER, W., MULDER, M.P., LANGEVELD, J.C.M., SMIT, E.M.E., BOS, J.L., BOOTSMA, D., and HOEIJMAKERS, J.H.J., Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site. Cancer Res., 49, 2129-1235 (1989).
13. KRAUS, A., MASAT, L. and JOHNSON, J.P., Analysis of the expression of ICAM-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, nonglycosylated antigen. Melanoma Res., 7 , S75-S81 (1997).
14. LEHMANN, J.M., HOLZMANN, B., BREITBART, E.W., SCHMIEGELOW, P., RIETHMÜLLER, G. and JOHNSON, J.P., Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res., 47, 841-845 (1987).
15. LEHMANN, J.M., RIETHMÜLLER, G., and JOHNSON, J.P., MUC18, a marker of tumor progression in human melanoma, shows sequence similarity of the neural cell adhesion molecules of the immunoglobulin superfamily. Proc. nat. Acad. Sci. (Wash.), 86, 9891-9895 (1989).
16. LUCA, M., HUNT, B., BUCANA, C.D., JOHNSON, J.P., FIDLER, I.J. and BAR-ELI, M., Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res., 3, 35-41 (1993).
17. MUELLER, B.M., ROMERDAHL, C.A., TRENT, J.M., and REISFELD, R.A., Suppression of spontaneous melanoma metastasis in seid mice with an antibody to the epidermal growth factor receptor. Cancer Res., 51, 2193-2198 (1991).
18. 3, in melanoma metastasis Cancer Metastasis Rev., 14, 241-252 (1995).
19. PICKL, W.F., MAJDIC, O., FISCHER, G.F., PETZELBAUER, P., FAE, I., WACLAVICEK, M., STÖCKL. J., SCHEINECKER, C., VIDICKI, T., ASCHAUER, H., JOHNSON, J.P. and KNAPP, W., MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J. Immunol., 158, 2107-2115 (1997).
20. POURQUIE, O., CORBEL, C., LE CAER, J.-P., ROSSIER, J. and LE DOUARIN, N.M., BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc. nat. Acad. Sci. (Wash.), 89, 5261-5265 (1992).
21. 3 in the disruption of the tumor vasculature induced by TNF and INF-gamma. Nature Med., 4, 408-414, 1998.
22. SEKIYA, T., FUSHIMI, M., HORI, H., HIROHASHI, S., NISHIMURA, S., and SUGIMURA, T., Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient. Proc. nat. Acad. Sci. (Wash.), 81, 4771-4775 (1984).
23. SEKIYA, T., HIROHASHI, S., NISHIMURA, S. and SUGIMURA, T., Transforming activity of human melanoma. Gann, 74, 794-795 (1983).
24. SERS, C., KIRSCH, K., ROTBÄCHER, U., RIETHMÜLLER, G. and JOHNSON, J.P., Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. Proc. nat. Acad. Sci. (Wash.), 90, 8514-8518 (1993).
25. SHIH, I.M., ELDER, D.E., SPEICHER, D., JOHNSON, J.P. and HERLYN, M., Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res., 54, 2514-2520 (1994).
26. SHIH, I.M., SPEICHER, D., HSU, M.Y., LEVINE, E. and HERLYN, M., Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand interactions. Cancer Res., 57, 3835-3840 (1997).
27. + hemopoietic precursors. J. Cell Biol., 13, 1655-1668 (1996).
28. XIE, S., LUCA, M., HUANG. S., GUTMAN, M., REICH, R., JOHNSON, J. P. and BAR-ELI, M., Expression of MCAM / MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res., 57, 2295-2303 (1997).
29. XIE, X., BRÜNNER, N., JENSEN, G., ALBRECHTSEN, J., GOTTHARDSEN, B. and RYGAARD, J. Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors. Clin. exp. Metastasis, 10, 201-210 (1992).